38 73

Cited 0 times in

First-in-human safety, pharmacokinetics, and preliminary efficacy of TPX-0022, a novel inhibitor of MET/SRC/CSF1R in patients with advanced solid tumors harboring genetic alterations in MET

DC Field Value Language
dc.contributor.author조병철-
dc.date.accessioned2021-09-29T02:29:13Z-
dc.date.available2021-09-29T02:29:13Z-
dc.date.issued2020-10-
dc.identifier.issn0959-8049-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/184929-
dc.description.statementOfResponsibilityopen-
dc.languageEnglish-
dc.publisherElsevier Science Ltd-
dc.relation.isPartOfEUROPEAN JOURNAL OF CANCER-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titleFirst-in-human safety, pharmacokinetics, and preliminary efficacy of TPX-0022, a novel inhibitor of MET/SRC/CSF1R in patients with advanced solid tumors harboring genetic alterations in MET-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthorD. Hong-
dc.contributor.googleauthorL. Bazhenova-
dc.contributor.googleauthorB.C. Cho-
dc.contributor.googleauthorS. Sen-
dc.contributor.googleauthorM. Ponz-Sarvise-
dc.contributor.googleauthorR. Heist-
dc.contributor.googleauthorZ. Zimmerman-
dc.contributor.googleauthorX. Le-
dc.contributor.googleauthorD. Xuan-
dc.contributor.googleauthorZ. Junming-
dc.contributor.googleauthorJ. Lee-
dc.contributor.localIdA03822-
dc.relation.journalcodeJ00809-
dc.identifier.eissn1879-0852-
dc.contributor.alternativeNameCho, Byoung Chul-
dc.contributor.affiliatedAuthor조병철-
dc.citation.volume138-
dc.citation.startPageS1-
dc.identifier.bibliographicCitationEUROPEAN JOURNAL OF CANCER, Vol.138 : S1, 2020-10-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.